07:35 AM EDT, 07/31/2025 (MT Newswires) -- Integra LifeSciences Holdings ( IART ) reported Q2 non-GAAP earnings Thursday of $0.45 per diluted share, down from $0.63 a year earlier.

Analysts surveyed by FactSet expected $0.44.

Revenue for the quarter ended June 30 was $415.6 million, down from $418.2 million a year earlier.

Analysts surveyed by FactSet expected $395 million.

For the third quarter, the company said it expects adjusted EPS of $0.40 to $0.45 on revenue of $410 million to $420 million.

Analysts surveyed by FactSet expect adjusted EPS of $0.58 on revenue of $418.8 million.

For fiscal 2025, the company said it is still expecting adjusted EPS $2.19 to $2.29 on updated revenue guidance of $1.66 billion to $1.68 billion. Previous guidance was $1.65 billion to $1.72 billion

Analysts surveyed by FactSet are expecting adjusted EPS of $2.24 on revenue of $1.67 billion.